WAT-released FFAs, for example, can play a key role in the induction of inflammation and insulin resistance via the activation of the toll-like receptor (TRL)-4/NF-κB/JNK signalling in the hypothalamus [8]. This evidence concerns the gene MAPK8 and Insulin resistance.